ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor ModelsCherrie K. Donawho, David J. Frost, Velitchka Bontcheva-Diaz et al.|Clinical Cancer Research|2007Cited by 770
Potent and selective inhibitors of Akt kinases slow the progress of tumors <i>in vivo</i>Yan Luo, Vincent L. Giranda, Alexander R. Shoemaker et al.|Molecular Cancer Therapeutics|2005Cited by 244
Janus Kinase 2 Determinants for Growth Hormone Receptor Association, Surface Assembly, and SignalingKai He, Stuart J. Frank, Xiangdong Wang et al.|Molecular Endocrinology|2003Cited by 58